Combination of Oncolytic Measles Virus and Ursolic Acid Synergistically Induces Oncolysis of Hepatocellular Carcinoma Cells.
drug combination
hepatitis B virus
hepatitis C virus
hepatocellular carcinoma
measles virus
oncolytic virotherapy
ursolic acid
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
31 05 2023
31 05 2023
Historique:
received:
07
04
2023
revised:
22
05
2023
accepted:
28
05
2023
medline:
29
6
2023
pubmed:
28
6
2023
entrez:
28
6
2023
Statut:
epublish
Résumé
Hepatocellular carcinoma (HCC) remains a difficult-to-treat cancer due to late diagnosis and limited curative treatment options. Developing more effective therapeutic strategies is essential for the management of HCC. Oncolytic virotherapy is a novel treatment modality for cancers, and its combination with small molecules merits further exploration. In this study, we combined oncolytic measles virus (MV) with the natural triterpenoid compound ursolic acid (UA) and evaluated their combination effect against HCC cells, including those harboring hepatitis B virus (HBV) or hepatitis C virus (HCV) replication. We found that the combination of MV and UA synergistically induced more cell death in Huh-7 HCC cells through enhanced apoptosis. In addition, increased oxidative stress and loss of mitochondrial potential were observed in the treated cells, indicating dysregulation of the mitochondria-dependent pathway. Similar synergistic cytotoxic effects were also found in HCC cells harboring HBV or HCV genomes. These findings underscore the potential of oncolytic MV and UA combination for further development as a treatment strategy for HCC.
Identifiants
pubmed: 37376594
pii: v15061294
doi: 10.3390/v15061294
pmc: PMC10302104
pii:
doi:
Substances chimiques
Antineoplastic Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Molecules. 2018 Aug 13;23(8):
pubmed: 30104508
Gene Ther. 2013 Nov;20(11):1033-41
pubmed: 23719065
J Agric Food Chem. 2010 May 26;58(10):6110-8
pubmed: 20415421
Int J Mol Sci. 2019 Sep 26;20(19):
pubmed: 31561416
J Hepatol. 2013 Nov;59(5):999-1006
pubmed: 23867315
Cancers (Basel). 2021 Jan 04;13(1):
pubmed: 33406633
Pharmacol Rev. 2006 Sep;58(3):621-81
pubmed: 16968952
Int J Mol Sci. 2020 Dec 10;21(24):
pubmed: 33321911
J Virol. 2015 Jan;89(1):811-23
pubmed: 25355880
Int J Oncol. 2017 Aug;51(2):555-562
pubmed: 28714512
Proc Natl Acad Sci U S A. 1987 Feb;84(4):1005-9
pubmed: 3029758
Front Immunol. 2023 Jan 23;13:1038226
pubmed: 36755812
Pharmacol Res. 2022 Aug;182:106306
pubmed: 35714823
Chin Clin Oncol. 2021 Feb;10(1):4
pubmed: 32527114
J Thorac Oncol. 2014 Aug;9(8):1101-10
pubmed: 25157763
Ann Oncol. 2018 Oct 1;29(Suppl 4):iv238-iv255
pubmed: 30285213
Toxicol Res (Camb). 2021 Apr 12;10(3):369-375
pubmed: 34141150
J Agric Food Chem. 2011 Mar 9;59(5):1713-22
pubmed: 21314126
Oncol Lett. 2019 Jun;17(6):4761-4767
pubmed: 31186681
Oncol Lett. 2019 Nov;18(5):5534-5542
pubmed: 31612061
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Mol Ther Oncolytics. 2015 Oct 07;2:15019
pubmed: 27119111
Asian J Pharm Sci. 2023 Jan;18(1):100771
pubmed: 36896445
Cancers (Basel). 2021 Feb 01;13(3):
pubmed: 33535479
Hepatology. 2008 Dec;48(6):1843-50
pubmed: 19003912
J Hepatol. 2022 Dec;77(6):1598-1606
pubmed: 36208844
J Hepatol. 2015 Mar;62(3):541-8
pubmed: 25450204
Gene Ther. 2008 Jul;15(14):1024-34
pubmed: 18356818
Phytomedicine. 2021 Aug;89:153611
pubmed: 34144429
Int J Oncol. 2016 Nov;49(5):1931-1944
pubmed: 27601235
Mol Cell Biochem. 2015 Apr;402(1-2):63-74
pubmed: 25547067
PLoS Pathog. 2011 Aug;7(8):e1002240
pubmed: 21901103
J Virol. 1995 Jun;69(6):3955-8
pubmed: 7745753
Clin Cancer Res. 2007 Dec 1;13(23):7155-65
pubmed: 18056196
World J Gastroenterol. 2006 Feb 14;12(6):874-9
pubmed: 16521214
Ann Oncol. 2021 Jun;32(6):801-805
pubmed: 33716105
Front Oncol. 2019 Jan 15;8:676
pubmed: 30697531
Cancer Res. 1993 Sep 1;53(17):3976-85
pubmed: 8358726
FEBS J. 2015 Jan;282(2):224-58
pubmed: 25393971
Biochem Pharmacol. 2013 Jun 1;85(11):1579-87
pubmed: 23499879
Sci Rep. 2019 May 1;9(1):6767
pubmed: 31043633
Cancer Cell Int. 2022 Dec 10;22(1):399
pubmed: 36496432
Antioxidants (Basel). 2021 Jul 21;10(8):
pubmed: 34439409
Hepatology. 2006 Dec;44(6):1465-77
pubmed: 17133484
Anticancer Res. 2019 Jul;39(7):3727-3737
pubmed: 31262899
Nat Rev Dis Primers. 2021 Jan 21;7(1):6
pubmed: 33479224
Mol Ther Oncolytics. 2018 Dec 31;12:147-161
pubmed: 30775418
Antiviral Res. 2013 Apr;98(1):44-53
pubmed: 23422646
J Biomed Biotechnol. 2011;2011:419343
pubmed: 21716649
Mol Cancer. 2020 Nov 10;19(1):158
pubmed: 33172438
Molecules. 2016 Nov 30;21(12):
pubmed: 27916903